Skip to content

Search

Senate HELP Committee Holds Heidi Overton's FDA Commissioner Hearing · Chronopin

HealthPosted 09/23/202609/23/2026 at 2:43 pm·@HealthDesk To timeline

U.S. Food and Drug Administration

Senate HELP Committee Holds Heidi Overton's FDA Commissioner Hearing

Senate HELP Committee Holds Heidi Overton's FDA Commissioner Hearing

Starts 09/24/2026 2:30PM

430 Dirksen Senate Office Building, Washington, D.C.

Tags

Policy
Abortion Pill
Confirmation Hearing
FDA
Heidi Overton
Vaccines

Comments

Given as scheduled, per help.senate.gov^[1][3]: "Date: Thursday, September 24, 2026 / Time: 10:30 AM ET/ 9:30 AM CT / Location: 430 Dirksen Senate Office Building"; it takes place "directly after the HELP Committee votes" on other nominations, so it may start a little later.

Start: Sep 24, 202675% CONFIDENCEfrom the source

Senate HELP Committee Holds Heidi Overton's FDA Commissioner Hearing

The Senate HELP Committee questions Dr. Heidi Overton, President Trump's pick for FDA commissioner, at 10:30 a.m. ET in 430 Dirksen. If confirmed, the White House domestic policy aide would take over an agency that has lost more than 3,000 staff in the past year.

The Senate HELP Committee holds the confirmation hearing for Dr. Heidi Overton as Commissioner of Food and Drugs on Thursday, September 24, 2026, at 10:30 a.m. ET in 430 Dirksen Senate Office Building; she is the only witness^[1]
The hearing follows straight after the committee votes on several HHS and National Mediation Board nominees and on a bill against student aid fraud, and will be streamed live^[3]
Trump announced the pick on social media on August 19 ("Dr. Heidi has been a ROCKSTAR in my Administration"); a senior official said she was his third choice, after Brad Wenstrup and acting commissioner Kyle Diamantas turned the job down^[6]
Overton is a preventive medicine physician and deputy director of the White House Domestic Policy Council, previously at the America First Policy Institute; she would replace Marty Makary, who resigned in May after 13 months^[4]
She would take over an FDA that has lost more than 3,000 staff over the past year, including division heads, amid low morale and fights over vaccines, the abortion pill and drug approvals^[4]
She spoke at the August 10 signing of Trump's executive order cutting back the childhood vaccine schedule, and has questioned letting medication abortion be prescribed by telehealth^[5]
HELP Chair Bill Cassidy said he has "strong concerns" about her lack of management experience and her role in the vaccine order; Sen. Patty Murray said she will vote no; Republicans hold the committee by one seat^[6]
Former FDA commissioners Scott Gottlieb and Mark McClellan backed her and called the hearing "an early test, and an opening"^[2]

2

References 685% CONFIDENCE

The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.

[1]75%
help.senate.gov/hearings/nomination-of-heidi-overton-to-be-commissioner-of-food-and-drugs
help.senate.gov· Posted Sep 23, 2026· Starts Sep 24, 2026 ✓· 18% of score
Given as scheduled, per help.senate.gov^[3]: "Date: Thursday, September 24, 2026 / Time: 10:30 AM ET/ 9:30 AM CT / Location: 430 Dirksen Senate Office Building"; it takes place "directly after the HELP Committee votes" on other nominations, so it may start a little later.
[2]75%
Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA - STAT
statnews.com· Published Sep 22, 2026· 17% of score
Opinion by former commissioners Gottlieb and McClellan backing her ahead of 'Thursday's confirmation hearing'; used only for their stance.^[1]
[3]95%
NEXT WEEK: Senate HELP Committee to Hold Hearing on Nomination for FDA Commissioner
help.senate.gov· Published Sep 17, 2026· 17% of score
The committee's own press release: date, time (10:30 AM ET), room 430 Dirksen, the hearing follows the committee's votes, and there is a livestream.^[1]
[4]90%
US Senate Panel Sets Hearing for Trump's FDA Pick - Reuters via US News
usnews.com· Published Sep 17, 2026· 17% of score
Reuters confirms the 24 Sep hearing, the August nomination, more than 3,000 staff lost, Makary's May resignation, and the fights over vaccines and the abortion pill.^[1]
[5]85%
What to know about Dr. Heidi Overton, Trump's pick to lead the FDA - NPR
npr.org· Published Aug 20, 2026· 15% of score
Her background, the 18,000-person agency, her views on telehealth medication abortion, and her role at the Aug. 10 vaccine executive order.^[1]

Suggest a correction

Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most.

Comments

Thread

Respond to this Pin

1Senate HELP Committee Holds Heidi Overton's FDA Commissioner Hearing

More like this

Health09/23/2026@HealthDesk
FDA Authorizes Abbott's Libre Duo Glucose-Ketone Sensor
Abbott Laboratories…1360 South Loop Road, Alameda, Alameda County, California, 94502, United States
Starts 08/25/2026CONFIRMED 87% CONFIDENCE29 days agoThe release is datelined "ABBOTT PARK, Ill., Aug. 25, 2026" and says Abbott "today announced U.S. Food and Drug Administration (FDA^[2][3]) authorization of its Libre Duo 10 Day system"; the FDA's De Novo record gives the same decision date, 08/25/2026.
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable to continuously track both glucose and ketones, which alerts people with diabetes aged 2 and older to rising ketones before diabetic ketoacidosis.
0.53
Health09/23/2026@HealthDesk
Abbott and Google Partner on Lingo Glucose Insights and AI Coaching
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 08/11/2026CONFIRMED 85% CONFIDENCE43 days agoThe release is datelined "ABBOTT PARK, Ill., Aug. 11, 2026" and says Abbott "today announced a first-of-its-kind partnership with Google Health".^[1]
Abbott and Google Health launched a multi-year partnership to bring glucose data from Abbott's over-the-counter Lingo sensor into the Google Health app, where Google's AI Health Coach will use it for personalized advice. The deal includes one of the largest real-world metabolic health studies.
0.52
Health09/23/2026@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
Starts 09/14/2026CONFIRMED 88% CONFIDENCE9 days agoThe release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.52
Elections09/20/2026@OddsDesk
Texas Picks a U.S. Senator in the 2026 Midterms
Texas State Capitol, 1100 Congress Avenue, Austin, Texas
Starts 11/03/2026SCHEDULED 72% CONFIDENCEin 41 daysPolymarket^[1][2] resolves on "the winner of the 2026 midterm Texas U.S. Senate election"; federal law sets Election Day on November 3, 2026, and the market's own end date is that day.
Polymarket
Polymarket
Texas votes for a U.S. Senate seat on November 3, 2026. On 20 September 2026 Polymarket had Democrat James Talarico at 60% against Republican Ken Paxton at 42%, and its companion market gave Democrats a 61% chance of taking the chamber.
0.52
Health09/20/2026@HealthDesk
Enicepatide's Phase 3 Trial in Obesity or Overweight Reads Out
RocheBasel, Canton of Basel-Stadt, Switzerland
Starts 07/24/2028ESTIMATED 50% CONFIDENCEin 1.8 yearsClinicalTrials.gov^[1] lists 2028-07-24 as the estimated primary completion date; a sponsor's estimate, and trials of this size routinely slip.
Roche's phase 3 trial of Enicepatide in obesity or overweight reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 2,000 participants. The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA), at multiple doses compared with placebo for weight management in participants without Type 2 diabetes mellitus (T2DM) who have obesity or overweight with at least one weight-related comorbidity.
0.52
Health09/23/2026@HealthDesk
FDA Approves Icotyde, the First Oral IL-23 Receptor Pill for Psoriasis
Johnson & Johnson…Spring House, Lower Gwynedd Township, Montgomery County, Pennsylvania, 19477, United States
Starts 03/17/2026 8:12PMCONFIRMED 88% CONFIDENCE190 days agoThe FDA's^[4] approval letter for NDA 220149 says the application "is approved, effective on the date of this letter" and was electronically signed "03/17/2026 04:12:23 PM" (Eastern, 20:12 UTC); J&J announced it the next morning: "SPRING HOUSE, Pa. (March 18, 2026) - ... announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE".
The FDA approved Johnson & Johnson's Icotyde (icotrokinra), a once-daily pill and the first targeted oral peptide to block the IL-23 receptor, for moderate-to-severe plaque psoriasis in adults and children 12 and older weighing at least 40 kg.
0.51
Finance05/09/2023@ThePinGang
FOMC Participant's Assessments Of Appropriate Monetary Policy: "DOT-PLOT"
Federal Reserve
Starts 03/22/2023 UNVERIFIED 89% CONFIDENCE3.5 years ago
0.50
Health09/23/2026@HealthDesk
Lilly Submits Retatrutide to the FDA for Approval
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
Starts 03/31/2027ESTIMATED3 months late77% CONFIDENCEin 189 daysLilly "plans to subsequently submit retatrutide in Q1 2027 for U.S. approval" - no day is given, so the pin takes the last day of the first quarter of 2027.^[1]
Lilly plans to file its Biologics License Application for retatrutide, the triple-hormone obesity shot that cut weight by up to 28.3% in Phase 3, with the FDA in the first quarter of 2027, once its manufacturing data package is complete.
0.50
Justice09/23/2026@LawDesk
Judge Approves the DOJ's HPE-Juniper Settlement Over States' Objections
Robert F. Peckham United States Courthouse and Federal Building, 280 South 1st Street, San Jose, California 95113, United States
Starts 08/12/2026CONFIRMED 85% CONFIDENCE42 days agoThe order granting the motion for entry of final judgment (Case 5:25-cv-00951-PCP, Document 482) is 'Filed 08/12/26' and signed 'Dated: August 12, 2026' by P. Casey Pitts; no time is given, so it is an all-day date.^[1]
Judge P. Casey Pitts entered the consent decree clearing HPE's Juniper Networks deal in a 41-page order that found DOJ leadership overrode its own antitrust staff, but held that 12 states and DC had not shown the Instant On sale and Mist source-code licence were against the public interest.
0.50
Climate09/23/2026@ClimateDesk
Amazon Commits $20M to Colorado River Water Conservation
Amazon…Hoover Dam, Mohave County, Arizona, United States
Starts 09/21/2026CONFIRMED 81% CONFIDENCE2 days agoAmazon's announcement, published September 21, 2026, says "Amazon is launching the Colorado River Basin Collaborative (CRBC) and plans to invest $20 million".^[1]
Amazon pledges $20 million and launches the Colorado River Basin Collaborative, a corporate coalition with Aldi, The Coca-Cola Foundation, Ecolab and others that aims to raise $100 million for water projects across the basin in two years.
$20M
0.49
Law09/23/2026@LawDesk
Ninth Circuit Rejects Bid to Block Sable Offshore Pipeline Restart
Sable Offshore…US Court of Appeals 9 Circuit, 95, 7th Street, South of Market, Tenderloin, San Francisco, California, 94103, United States
Starts 12/31/2025CONFIRMED 87% CONFIDENCE266 days agoStated as an accomplished fact, per independent.com^[1]: "The December 31 court ruling was terse, offering no insights as to how the judges arrived at their conclusion."
A two-judge Ninth Circuit panel turned down an emergency appeal by the Environmental Defense Center and Center for Biological Diversity seeking to block the federal restart permit granted to Sable Offshore's Santa Ynez Unit pipelines, sending the company's stock surging. The terse December 31 order is not the end: the court put the case on an expedited schedule, with its first deadline on January 26.
0.49
Energy09/23/2026@EnergyDesk
B&W Gets Go-Ahead to Supply SolveBright Carbon Capture to a US Power Plant
1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United StatesBabcock & Wilcox…
Starts 12/08/2025 11:30AMCONFIRMED 82% CONFIDENCE289 days agoStated as done, per B&W's release "(AKRON, Ohio – December 8, 2025)": "announced today that it has received limited notice to proceed"; the Business Wire copy on Yahoo Finance is timestamped 2025-12-08T11:30:00Z (6:30 a.m. ET).^[1]
Babcock & Wilcox received a limited notice to proceed on engineering and long-lead purchasing for a SolveBright CO2-capture system at an unnamed existing US power plant, sized to capture more than 550,000 tons a year. The full contract, expected by March 2026, is worth an estimated $80 million; the plant is not named, so the pin sits at B&W's Akron headquarters.
$80M
0.49